Clinical Use of Recombinant FVIIa (rFVIIa)

By Hedner U.   Ingerslev J.  

Transfusion and Apheresis Science, Vol. 19, Iss. 2, 1998-06 ,pp. : 163-176

Elsevier

Access to resources Recommend Favorite

An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A

By Rea Catherine   Foley Jonathan   Bevan David   Sørensen Benny  

Annals of Hematology, Vol. 93, Iss. 4, 2014-04 ,pp. : 683-692

Springer Publishing Company

Access to resources Recommend Favorite

Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias

By Girolami Antonio   de Marinis Giulia Berti   Bonamigo Emanuela   Lombardi Anna Maria  

Hematology, Vol. 17, Iss. 6, 2012-11 ,pp. : 346-349

Maney Publishing

Access to resources Recommend Favorite

Expression, purification, characterization and clinical relevance of rAed a 1—a 68-kDa recombinant mosquito Aedes aegypti salivary allergen

By Peng Zhikang  

International Immunology, Vol. 13, Iss. 12, 2001-12 ,pp. : 1445-1452

Oxford University Press

Access to resources Recommend Favorite

The clinical use of tramadol hydrochloride

By Bamigbade T.   Langford R.  

Pain reviews, Vol. 5, Iss. 3, 1998-10 ,pp. : 155-182

Hodder Arnold Journals

Access to resources Recommend Favorite